2011
DOI: 10.1242/jcs.073585
|View full text |Cite
|
Sign up to set email alerts
|

Loss of keratins 8 and 18 leads to alterations in α6β4-integrin-mediated signalling and decreased neoplastic progression in an oral-tumour-derived cell line

Abstract: Keratins 8 and 18 (K8 and K18) are predominantly expressed in simple epithelial tissues and perform both mechanical and regulatory functions. Aberrant expression of K8 and K18 is associated with neoplastic progression and invasion in squamous cell carcinomas (SCCs). To understand the molecular basis by which K8 promotes neoplastic progression in oral SCC (OSCC), K8 expression was inhibited in AW13516 cells. The K8-knockdown clones showed a significant reduction in tumorigenic potential, which was accompanied b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

11
77
2
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
10

Relationship

6
4

Authors

Journals

citations
Cited by 55 publications
(91 citation statements)
references
References 56 publications
11
77
2
1
Order By: Relevance
“…αvβ6 integrin was found to be significantly upregulated in certain cancer types including colon (18,26) and ovarian carcinoma (27) and in early stage non-small cell lung cancer (NSCLC) (28). In the present study, β6 integrin expression was upregulated in many breast cancer samples and high expression of β6 integrin was found to be associated with poor prognosis.…”
Section: Discussionsupporting
confidence: 47%
“…αvβ6 integrin was found to be significantly upregulated in certain cancer types including colon (18,26) and ovarian carcinoma (27) and in early stage non-small cell lung cancer (NSCLC) (28). In the present study, β6 integrin expression was upregulated in many breast cancer samples and high expression of β6 integrin was found to be associated with poor prognosis.…”
Section: Discussionsupporting
confidence: 47%
“…For the orthotopic mouse xenograft model, mice were sacrificed at the 13th week after injection, and the lungs and lymph nodes were inspected for metastasis, which were confirmed by H&E staining. To further determine the effect of KMD2A knockdown on tumorigenicity of H1792 cells, 2 × 10 6 cells were subcutaneously injected into the dorsal flank of 6-to 8-week-old nude mice as previously described (36). Control or KDM2A-depleted H1792 cells were suspended in RPMI without serum before injection.…”
Section: Methodsmentioning
confidence: 99%
“…KDM2A-depleted cells were generated using shRNA against KDM2A as described previously (21). KDM2A/ HDAC3-depleted cells were generated by treating KDM2A-depleted cells with 50 nM siHDAC3-9 using Lipofectamine RNAiMAX.…”
Section: Methodsmentioning
confidence: 99%